RN7SL48P

Across TCGA pan-cancer cohorts, RN7SL48P RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RN7SL48P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RN7SL48P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL48P expression acts as an unfavorable survival marker, although some lineages such as STAD and UCS show a favorable association.

LIHC, UVM, and THCA are the cancer types where RN7SL48P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Median	All	0.468	0.601	.004	37	view →
UVM	OS	Tertile	All	0.345	0.706	.024	24	view →
THCA	OS	Tertile	All	0.868	0.983	.007	20	view →
CHOL	OS	Quartile	II,III,IV	0.304	0.833	.025	18	view →
STAD	OS	Median	II,III,IV	0.737	0.613	.003	18	view →
LUSC	DFS	Quartile	III,IV	0.299	0.794	.015	14	view →
UCS	OS	Tertile	II,III,IV	0.733	0.311	.034	12	view →
CESC	OS	Quartile	IV	0.956	0.437	.040	8	view →
PRAD	DFS	Quartile	All	0.903	0.755	.035	6	view →
PAAD	OS	Tertile	II,III,IV	0.740	0.502	.011	5	view →
ACC	OS	Tertile	All	0.909	0.544	.044	4	view →
HNSC	DFS	Quartile	IV	0.791	0.507	.032	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RN7SL48P–LIHC (DFS)

Open the LIHC breakdown →